Quantcast
Last updated on April 18, 2014 at 14:37 EDT

IMRIS Sells IMRISneuro and iCT Systems to a Single U.S. Customer

August 24, 2011

WINNIPEG, Aug. 24, 2011 /PRNewswire/ – IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
(“IMRIS” or the “Company”) today announced the sale of two systems,
consisting of an IMRISneuro and an iCT system to a single confidential
U.S. customer during the first 45 days of the third quarter ending
September 30, 2011.

The installation will include an IMRISneuro system delivering on demand
intraoperative MR imaging and an iCT system that will provide
intraoperative computed tomography imaging capabilities.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions.  These solutions feature fully integrated
surgical and interventional suites that incorporate magnetic resonance,
fluoroscopy and computed tomography to deliver on demand imaging during
procedures. The Company’s systems serve the neurosurgical,
cardiovascular and neurovascular markets and have been selected by
leading medical institutions around the world.


SOURCE IMRIS Inc.


Source: PR Newswire